about
Antimicrobial activity of short, synthetic cationic lipopeptides.HSP90 inhibition sensitizes head and neck cancer to platin-based chemoradiotherapy by modulation of the DNA damage response resulting in chromosomal fragmentation.Radiosensitization by the ATR Inhibitor AZD6738 through Generation of Acentric Micronuclei.An orally bioavailable Chk1 inhibitor, CCT244747, sensitizes bladder and head and neck cancer cell lines to radiation.CHK1 Inhibition Radiosensitizes Head and Neck Cancers to Paclitaxel-Based Chemoradiotherapy.Oncolytic vaccinia virus as a vector for therapeutic sodium iodide symporter gene therapy in prostate cancer.Synergistic cytotoxicity of radiation and oncolytic Lister strain vaccinia in (V600D/E)BRAF mutant melanoma depends on JNK and TNF-α signaling.Targeted radiosensitization by the Chk1 inhibitor SAR-020106.Genetically modified lentiviruses that preserve microvascular function protect against late radiation damage in normal tissues.Trametinib radiosensitises RAS- and BRAF-mutated melanoma by perturbing cell cycle and inducing senescence.Combined ATR and DNA-PK Inhibition Radiosensitizes Tumor Cells Independently of Their p53 StatusInflammatory microenvironment remodelling by tumour cells after radiotherapyATR Inhibition Potentiates the Radiation-induced Inflammatory Tumor MicroenvironmentPD-1 Blockade Following Isolated Limb Perfusion with Vaccinia Virus Prevents Local and Distant Relapse of Soft-tissue Sarcoma
P50
Q33550548-FB440502-05A9-46B5-8CF5-D1DA99748F22Q37615630-C1B7D3E8-411D-4C2F-8181-91B625821E17Q37635766-7657BE37-7A1F-4B9D-9383-0468B8B52171Q38718996-2482D095-DE38-43E2-AB07-8D0D7200C65BQ38757867-480AC7EE-77EE-4470-8FC7-3D7F0A4AC25BQ38799217-5960DA1D-3682-49E2-B036-20B7FD1FAB8CQ39159172-24EF5746-0F05-4308-B806-ECA15FA455F4Q39278299-60C8AAF3-1ADE-4EF8-90DE-75EEEEB06702Q48172462-4048E233-68FD-410C-ADFC-221A2914F74EQ52931908-9882768E-D4DD-4E90-A01B-C455BC717B77Q57176137-4D62B144-0093-440E-9531-8EC682C1B614Q90246592-BE9B8C58-923A-4171-9AC3-BC8C7F7D117AQ91632394-06513FBB-61A8-40E1-96EF-9978AD979B6EQ92458703-8EE8622D-23EF-4DD2-BD17-6F786B5B92C2
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Martin McLaughlin
@en
Martin McLaughlin
@nl
type
label
Martin McLaughlin
@en
Martin McLaughlin
@nl
prefLabel
Martin McLaughlin
@en
Martin McLaughlin
@nl
P31
P496
0000-0002-9739-7133